{"id":"https://openalex.org/W2409903753","doi":"https://doi.org/10.1177/030089160008600306","title":"A Phase II Study of Paclitaxel/Cisplatin Combination in Patients with Metastatic Breast Cancer Refractory to Anthracycline-Based Chemotherapy","display_name":"A Phase II Study of Paclitaxel/Cisplatin Combination in Patients with Metastatic Breast Cancer Refractory to Anthracycline-Based Chemotherapy","alternate_titles":[],"publication_year":2000,"publication_date":"2000-05-01","ids":{"openalex":"https://openalex.org/W2409903753","doi":"https://doi.org/10.1177/030089160008600306","mag":"2409903753","pmid":"https://pubmed.ncbi.nlm.nih.gov/10939600"},"language":"en","primary_location":{"id":"doi:10.1177/030089160008600306","doi":"https://doi.org/10.1177/030089160008600306","is_oa":false,"landing_page_url":"https://doi.org/10.1177/030089160008600306","pdf_url":null,"source":{"id":"https://openalex.org/S4210189328","display_name":"Tumori Journal","issn_l":"0300-8916","issn":["0300-8916","2038-2529"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tumori Journal","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2409903753"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014792832","display_name":"Gerardo Rosati","orcid":"https://orcid.org/0000-0001-7004-6862","observed_orcids":["https://orcid.org/0000-0001-7004-6862"]},"institutions":[{"id":"https://openalex.org/I4210102152","display_name":"Ospedale San Carlo","ror":"https://ror.org/01d86hn60","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210102152"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gerardo Rosati","raw_affiliation_strings":["Division of Medical Oncology, \u201cSan Carlo'\u2019 Hospital, Potenza;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, \u201cSan Carlo'\u2019 Hospital, Potenza;","institution_ids":["https://openalex.org/I4210102152"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007382846","display_name":"Ferdinando Riccardi","orcid":"https://orcid.org/0000-0002-2852-2770","observed_orcids":["https://orcid.org/0000-0002-2852-2770"]},"institutions":[{"id":"https://openalex.org/I4210087768","display_name":"Ospedale Antonio Cardarelli","ror":"https://ror.org/003hhqx84","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210087768"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ferdinando Riccardi","raw_affiliation_strings":["Division of Medical Oncology, \u201cA. Cardarelli'\u2019 Hospital, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, \u201cA. Cardarelli'\u2019 Hospital, Naples, Italy","institution_ids":["https://openalex.org/I4210087768"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103932106","display_name":"Aniello Tucci","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087768","display_name":"Ospedale Antonio Cardarelli","ror":"https://ror.org/003hhqx84","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210087768"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Aniello Tucci","raw_affiliation_strings":["Division of Medical Oncology, \u201cA. Cardarelli'\u2019 Hospital, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, \u201cA. Cardarelli'\u2019 Hospital, Naples, Italy","institution_ids":["https://openalex.org/I4210087768"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048054764","display_name":"Patrizia De Rosa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087768","display_name":"Ospedale Antonio Cardarelli","ror":"https://ror.org/003hhqx84","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210087768"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Patrizia De Rosa","raw_affiliation_strings":["Division of Medical Oncology, \u201cA. Cardarelli'\u2019 Hospital, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, \u201cA. Cardarelli'\u2019 Hospital, Naples, Italy","institution_ids":["https://openalex.org/I4210087768"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071918431","display_name":"Giovanni Pacilio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087768","display_name":"Ospedale Antonio Cardarelli","ror":"https://ror.org/003hhqx84","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210087768"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Giovanni Pacilio","raw_affiliation_strings":["Division of Medical Oncology, \u201cA. Cardarelli'\u2019 Hospital, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, \u201cA. Cardarelli'\u2019 Hospital, Naples, Italy","institution_ids":["https://openalex.org/I4210087768"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":0.6512,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":{"value":0.68255781,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"86","issue":"3","first_page":"207","last_page":"210"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0071000000461936,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9440000057220459},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9710000157356262},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":1.0},{"id":"https://openalex.org/keywords/anthracycline-resistance","display_name":"anthracycline resistance","score":0.859000027179718},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.7099999785423279},{"id":"https://openalex.org/keywords/neurotoxicity","display_name":"neurotoxicity","score":0.7519999742507935},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.9020000100135803},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.6380000114440918},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.5180000066757202}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9067956209182739},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.7050325274467468},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6949490308761597},{"id":"https://openalex.org/C2776802502","wikidata":"https://www.wikidata.org/wiki/Q417589","display_name":"Anthracycline","level":4,"score":0.672721266746521},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6472743153572083},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.635159432888031},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6113477349281311},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5903735756874084},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.5795012712478638},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.5467705130577087},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.48099789023399353},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.45214730501174927},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.438178688287735},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4368676543235779},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4344763159751892},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.42566025257110596},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.41392961144447327},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3561636209487915}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000903","descriptor_name":"Antibiotics, Antineoplastic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010523","descriptor_name":"Peripheral Nervous System Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1177/030089160008600306","doi":"https://doi.org/10.1177/030089160008600306","is_oa":false,"landing_page_url":"https://doi.org/10.1177/030089160008600306","pdf_url":null,"source":{"id":"https://openalex.org/S4210189328","display_name":"Tumori Journal","issn_l":"0300-8916","issn":["0300-8916","2038-2529"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tumori Journal","raw_type":"journal-article"},{"id":"pmid:10939600","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10939600","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tumori","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W21740694","https://openalex.org/W1723772693","https://openalex.org/W1776053979","https://openalex.org/W1984446074","https://openalex.org/W2045701290","https://openalex.org/W2046984288","https://openalex.org/W2049306821","https://openalex.org/W2117771496","https://openalex.org/W2134495718","https://openalex.org/W2150974445","https://openalex.org/W2167805334","https://openalex.org/W2252617423","https://openalex.org/W2415712440","https://openalex.org/W3041047318"],"related_works":["https://openalex.org/W2150974445","https://openalex.org/W2024961744","https://openalex.org/W3031672024","https://openalex.org/W2029287978","https://openalex.org/W2096955328","https://openalex.org/W2417415918","https://openalex.org/W2108868778","https://openalex.org/W2109815554"],"abstract_inverted_index":{"AIMS":[0],"AND":[1,33],"BACKGROUND:":[2],"To":[3],"investigate":[4],"the":[5,72,137,140,191,204,209,216,236,271,284,289],"safety":[6],"and":[7,12,66,228,241],"efficacy":[8,290],"of":[9,19,71,106,123,139,184,212,218,273,291],"a":[10,16,69,79,116],"paclitaxel":[11,150,199,293],"cisplatin":[13,124],"regimen":[14,269],"in":[15,48,174,245,260,295],"selected":[17],"group":[18],"metastatic":[20,39,60,107,276],"breast":[21,40,277],"cancer":[22,41,278],"patients":[23,54,88,100,146,194,262,274],"with":[24,38,62,198,275],"primary":[25],"or":[26,44,77,92,103,164],"acquired":[27],"chemo-resistance":[28],"to":[29,148,223,280],"anthracycline-based":[30,281],"chemotherapy.":[31,282],"PATIENTS":[32],"METHODS:":[34],"Thirty-eight":[35],"consecutive":[36],"women":[37],"(PS":[42],"<":[43],"=2)":[45],"were":[46],"entered":[47],"this":[49],"phase":[50],"II":[51],"trial;":[52],"all":[53],"had":[55,67,89,101,202],"been":[56],"previously":[57],"treated":[58],"for":[59,96,133,190,248,270],"disease":[61,73,162],"chemotherapy":[63,142],"containing":[64],"anthracyclines":[65],"shown":[68],"progression":[70,163,224],"during":[74],"drug":[75],"administration":[76],"after":[78],"clinical":[80,170,206],"response":[81,171,186,207],"lasting":[82],"less":[83],"than":[84],"6":[85,134,226],"months.":[86,233],"Fifteen":[87],"received":[90],"2":[91],"more":[93],"chemotherapeutic":[94],"regimens":[95],"advanced":[97],"disease;":[98],"31":[99],">":[102],"=2":[104],"sites":[105],"disease.":[108],"Paclitaxel":[109],"(135":[110],"mg/m2)":[111,126,153],"was":[112,172,187,225,235],"administered":[113],"iv":[114,121],"by":[115,120],"3-hr":[117],"infusion":[118,122],"followed":[119],"(75":[125],"on":[127,155],"day":[128,156],"1,":[129,157],"every":[130,158],"3":[131,159],"weeks":[132],"cycles.":[135],"After":[136],"completion":[138],"planned":[141],"administration,":[143],"9":[144,192],"responsive":[145,193,296],"continued":[147,196],"receive":[149],"alone":[151],"(175":[152],"iv,":[154],"weeks,":[160],"until":[161],"unacceptable":[165],"toxicity.":[166],"RESULTS:":[167],"A":[168],"partial":[169,205],"recorded":[173],"17":[175],"cases":[176,247],"(45%;":[177],"95%":[178],"CI,":[179],"30-64%).":[180],"The":[181,220],"median":[182,210,221,229],"duration":[183],"overall":[185,230],"8":[188,232],"months;":[189],"who":[195],"treatment":[197,243,272],"alone,":[200],"4":[201],"maintained":[203],"at":[208],"follow-up":[211],"24":[213],"months":[214,227],"from":[215],"onset":[217],"therapy.":[219],"time":[222],"survival":[231],"Neurotoxicity":[234],"most":[237],"frequent":[238],"adverse":[239],"effect":[240],"caused":[242],"discontinuation":[244],"5":[246],"grade":[249],"3-4":[250,257],"paresthesia":[251],"and/or":[252],"an":[253,267],"arthralgia/myalgia":[254],"syndrome.":[255],"Grade":[256],"neutropenia":[258],"occurred":[259],"16":[261],"(44%).":[263],"CONCLUSIONS:":[264],"Paclitaxel/cisplatin":[265],"is":[266],"active":[268],"refractory":[279],"However,":[283],"cumulative":[285],"neurotoxicity":[286],"should":[287],"limit":[288],"prolonged":[292],"monotherapy":[294],"patients.":[297]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2409903753","counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
